Disintegration of simulated drinking water biofilms with arrays of microchannel plasma jets

A review of research advances on disinfection strategies for biofilm control in drinking water distribution systems

The presence of biofilms in drinking water distribution systems (DWDS) is responsible for water quality deterioration and a possible source of public health risks. Different factors impact the biological stability of drinking water (DW) in the distribution networks, such as the presence and concentration of nutrients, water temperature, pipe material composition, hydrodynamic conditions, and levels of disinfectant residual. This review aimed to evaluate the current state of knowledge on strategies for DW biofilm disinfection through a qualitative and quantitative analysis of the literature published over the last decade. A systematic review method was performed on the 562 journal articles identified through database searching on Web of Science and Scopus, with 85 studies selected for detailed analysis. A variety of disinfectants were identified for DW biofilm control such as chlorine, chloramine, UV irradiation, hydrogen peroxide, chlorine dioxide, ozone, and others at a lower frequency, namely, electrolyzed water, bacteriophages, silver ions, and nanoparticles. The disinfectants can impact the microbial communities within biofilms, reduce the number of culturable cells and biofilm biomass, as well as interfere with the biofilm matrix components. The maintenance of an effective residual concentration in the water guarantees long-term prevention of biofilm formation and improves the inactivation of detached biofilm-associated opportunistic pathogens. Additionally, strategies based on multi-barrier processes by optimization of primary and secondary disinfection combined with other water treatment methods improve the control of opportunistic pathogens, reduce the chlorine-tolerance of biofilm-embedded cells, as well as decrease the corrosion rate in metal-based pipelines. Most of the studies used benchtop laboratory devices for biofilm research. Even though these devices mimic the conditions found in real DWDS, future investigations on strategies for DW biofilm control should include the validity of the promising strategies against biofilms formed in real DW networks.

Flexible Cold Atmospheric Plasma Jet Sources

The properties of non-thermal atmospheric pressure plasma jets (APPJs) make them suitable for industrial and biomedical applications. They show many advantages when it comes to local and precise surface treatments, and there is interest in upgrading their performance for irradiation on large areas and uneven surfaces. The generation of charged species (electrons and ions) and reactive species (radicals), together with emitted UV photons, enables a rich plasma chemistry that should be uniform on arbitrary sample profiles. Lateral gradients in plasma parameters from multi-jets should, therefore, be minimized and addressed by means of plasma monitoring techniques, such as electrical diagnostics and optical emission spectroscopy analysis (OES). This article briefly reviews the main strategies adopted to build morphing APPJ arrays and ultra-flexible and long tubes to project cold plasma jets. Basic aspects, such as inter-jet interactions and nozzle shape, have also been discussed, as well as potential applications in the fields of polymer processing and plasma medicine.

Assessment of persistent antimicrobial and anti-biofilm activity of p-HEMA hydrogel loaded with rifampicin and cefixime

Catheter-associated urinary tract infections (CAUTIs) are nosocomial infections causing more than one million hospital cases annually. The progress of CAUTIs leads to severe health complications. Infections result in blockage of the medical device due to biofilm formation, which necessitates the replacement of the device. The objective of this study is to improve urological biomaterials to minimize microbial growth and reduce the incidence of CAUTIs. Challenges from mixed biofilm are crucial and need to be addressed in the development of new coating materials. Herein, an investigation highlighted the reduction of mixed biofilm overgrowth and attachment tendency on poly-2-hydroxyethyl methacrylate (p-HEMA) surface by loading the hydrogel with rifampicin (RIF), cefixime trihydrate (CFX), and combined ratios of RIF and CFX. Mixed biofilm-formation ability in (3:1) RIF: CFX-loading p-HEMA (F6) surface showed best tendency to resist form biofilm. Persistent antimicrobial activity increased in p-HEMA loaded with combined ratios of RIF and CFX surface compared to p-HEMA alone, antimicrobial activity lasted for 8 days. All fabricated films exhibited %cell viability higher than 75% on HEK 293 cells. The addition of RIF and CFX may improve the duration of urological device employment before replacement.

Non-thermal plasma multi-jet platform based on a flexible matrix

A new plasma source design that merges the main characteristics of capacitive dielectric barrier discharge (DBD) and cold atmospheric plasma jet (CAPJ) is discussed. The DBD system contains a flexible, porous matrix consisting of silica aerogel, which is comprised between two biased electrodes. The helium flow supply subjected to a sinusoidal voltage of around 5 kV in amplitude and 15 kHz in frequency provides a set of plasma jets that propagates more than 1 cm beyond the active DBD region. The studied plasma multi-jet system consists of an array of three aligned jets that flow in the laminar regime, and it is intended for treating the surfaces of 3D objects and large areas. CAPJ performance is discussed as a hypothetical morphing source in flat and bent configurations. Electrical characterization and optical emission spectroscopy diagnostics have provided current-voltage waveforms and the composition of the CAPJ through the aerogel layer, respectively. This novel source is promising for biomedical applications that require full adaptation of plasma parameters to delicate samples, such as wound healing and treatment of surgical margins in plasma-based cancer surgery.

Inactivation and sensitization of Pseudomonas aeruginosa by microplasma jet array for treating otitis media

Otitis media (OM), known as a middle ear infection, is the leading cause of antibiotic prescriptions for children. With wide-spread use of antibiotics in OM, resistance to antibiotics continues to decrease the efficacy of the treatment. Furthermore, as the presence of a middle ear biofilm has contributed to this reduced susceptibility to antimicrobials, effective interventions are necessary. A miniaturized 3D-printed microplasma jet array has been developed to inactivate Pseudomonas aeruginosa, a common bacterial strain associated with OM. The experiments demonstrate the disruption of planktonic and biofilm P. aeruginosa by long-lived molecular species generated by microplasma, as well as the synergy of combining microplasma treatment with antibiotic therapy. In addition, a middle ear phantom model was developed with an excised rat eardrum to investigate the antimicrobial effects of microplasma on bacteria located behind the eardrum, as in a patient-relevant setup. These results suggest the potential for microplasma as a new treatment paradigm for OM.

Fighting Mixed-Species Microbial Biofilms With Cold Atmospheric Plasma

Most biofilms in nature are formed by multiple microbial species, and such mixed-species biofilms represent the actual lifestyles of microbes, including bacteria, fungi, viruses (phages), and/or protozoa. Microorganisms cooperate and compete in mixed-species biofilms. Mixed-species biofilm formation and environmental resistance are major threats to water supply, food industry, and human health. The methods commonly used for microbial eradication, such as antibiotic or disinfectant treatments, are often ineffective for mixed-species biofilm consortia due to their physical matrix barrier and physiological interactions. For the last decade, an increasing number of investigations have been devoted to the usage of cold atmospheric plasma (CAP), which is produced by dielectric barrier discharges or plasma jets to prevent or eliminate microbial biofilms. Here, we summarized the production of CAP, the inactivation of microorganisms upon CAP treatment, and the microbial factors affecting the efficacy of CAP procedure. The applications of CAP as antibiotic alternative strategies for fighting mixed-species biofilms were also addressed.